HomeFilePeripheral vascular disease

Peripheral vascular disease

View Category

Femoropopliteal

Results of the COMPARE Study After 2 Years: Low Dose vs. High Dose Paclitaxel-Coated Balloons

The development of new devices and techniques has expanded the range of patients who benefit from endovascular...
solaci -
Learn More
Peripheral vascular disease

TEATE Trial: Urine Alkalinization as a Target to Prevent Contrast-Associated Kidney Injury

Acute kidney injury related to iodinated contrast significantly increases morbidity and mortality after angiography or angioplasty. According...
solaci -
Learn More
Other

TCT 2022 | Pulmonary Artery Denervation in Primary Pulmonary Hypertension

Primary Pulmonary Hypertension is behind multiple hospitalizations and pulmonary transplants. Even though its treatment has been advanced,...
solaci -
Learn More
Peripheral Vascular Disease

SYMPLICITY HTN-3 Trial. Evolution at 3 Years

The SYMPLICITY 3-year outcomes are out. Bear in mind this is the largest study we have had...
solaci -
Learn More
Peripheral vascular disease

TCT 2022 | RADIANCE II Pivotal Trial

Renal denervation has been developed to treat blood hypertension. Even though at present is still not common,...
solaci -
Learn More
Acute coronary syndromes

Gender Differences and 10-Year Prognosis in STEMI

Coronary artery disease in women usually develops 10 years later than in men, and some evidence suggests...
solaci -
Learn More
Peripheral vascular disease

RADIANCE-HTN SOLO: Control Durability of BP

In patients with hard-to-control high blood pressure (HBP), both non-pharmacological treatment and lifestyle changes have been useful...
solaci -
Learn More
Femoropopliteal

Clinical Results of IVUS-Guided Drug-Eluting Stent Implantation in Femoropopliteal Disease

Endovascular treatment of femoropopliteal lesions has become the first-line treatment due to the development of devices that...
solaci -
Learn More